Barclays Maintains an 'Overweight' on Chimera Investment Corp (CIM); Updating Estimates for 1Q11 Results
Tweet Send to a Friend
Barclays maintains an 'Overweight' on Chimera Investment Corp (NYSE: CIM), PT $5.
Barclays analyst says, "CIM reported 1Q11 core EPS ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "CIM reported 1Q11 core EPS ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
